Insider · CIK 0002103996
Kathryn W Kyle
Files at LH (LABORATORY CORP OF AMERICA HOLDINGS). First filing Jun 10, 2026, latest Jul 6, 2026.
In brief
Kathryn W Kyle files SEC Form 4 as officer at LH (LABORATORY CORP OF AMERICA HOLDINGS). Since Jun 10, 2026, Kathryn W Kyle has reported 0 open-market buys worth $0 and 2 open-market sells worth $227k, the latest filed on Jul 6, 2026.
A track record needs three past buys with six months of prices behind them; Kathryn W Kyle has 0, so none is measured yet.
The newest scored trade: sold $26k of LH on Jul 2, 2026, filed Jul 6, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $227k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LH: LABORATORY CORP OF AMERICA HOLDINGS
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | LABORATORY CORP OF AMERICA HOLDINGS | $26k 92 shares | -2% | +19% from low-1% from high | |
| 12Weak | LABORATORY CORP OF AMERICA HOLDINGS | $201k 762 shares | -17% | +9% from low-9% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 2, 2026 | LH LABCORP HOLDINGS INC. | 92 0.00% of outstanding | $26k | Jul 2, 2026 | $201k |
| Jun 8, 2026 | LH LABCORP HOLDINGS INC. | 762 0.00% of outstanding | $201k | Jun 8, 2026 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock10b5-1 | +256 | - | - | 4,069 | Jul 6, 2026 |
| Jul 1, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock10b5-1 | -73 | $283.88 | $21k | 3,996 | Jul 6, 2026 |
| Jul 2, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | SOpen-market sale Common Stock10b5-1 | -92 | $286.19 | $26k | 3,904 | Jul 6, 2026 |
| Jul 1, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative10b5-1 | -256 | $0.00 | $0 | 2,008 | Jul 6, 2026 |
| Jun 8, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | SOpen-market sale Common Stock10b5-1 | -762 | $263.89 | $201k | 3,813 | Jun 10, 2026 |
| Mar 26, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Common Stock | +1,584 | $0.00 | $0 | 5,026 | Mar 30, 2026 |
| Mar 26, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -451 | $268.38 | $121k | 4,575 | Mar 30, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +216 | - | - | 3,504 | Feb 13, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -62 | $289.89 | $18k | 3,442 | Feb 13, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -216 | $0.00 | $0 | 2,264 | Feb 13, 2026 |
| Feb 10, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Non-qualified Stock Optionsderivative | +2,700 | $0.00 | $0 | 2,700 | Feb 12, 2026 |
| Feb 10, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Restricted Stock Unitderivative | +880 | $0.00 | $0 | 2,480 | Feb 12, 2026 |
| Feb 6, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +180 | - | - | 3,232 | Feb 10, 2026 |
| Feb 6, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -61 | $277.20 | $17k | 3,171 | Feb 10, 2026 |
| Feb 7, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +178 | - | - | 3,349 | Feb 10, 2026 |
| Feb 9, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -61 | $274.01 | $17k | 3,288 | Feb 10, 2026 |
| Feb 6, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -180 | $0.00 | $0 | 1,778 | Feb 10, 2026 |
| Feb 7, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -178 | $0.00 | $0 | 1,600 | Feb 10, 2026 |
Questions about Kathryn W Kyle
Answered from the filings on this page, as of the latest one.
Is Kathryn W Kyle buying or selling?
In the last 12 months Kathryn W Kyle reported 0 open-market buys worth $0 and 2 open-market sells worth $227k on SEC Form 4; the latest was sold $26k of LH on Jul 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Kathryn W Kyle's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kathryn W Kyle has 0.
Where does Kathryn W Kyle file Form 4?
Kathryn W Kyle has filed Form 4 at LH (LABORATORY CORP OF AMERICA HOLDINGS) as EVP, Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.